These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28334911)

  • 1. MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
    Musso G; Cassader M; De Michieli F; Paschetta E; Pinach S; Saba F; Bongiovanni D; Framarin L; Berrutti M; Leone N; Corvisieri S; Parente R; Molinaro F; Sircana A; Bo S; Gambino R
    Hum Mol Genet; 2017 May; 26(9):1747-1758. PubMed ID: 28334911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
    Musso G; Saba F; Cassader M; Paschetta E; De Michieli F; Pinach S; Framarin L; Berrutti M; Leone N; Parente R; Ayoubi Khajekini MT; Zarovska A; Gambino R
    Am J Gastroenterol; 2019 Apr; 114(4):607-619. PubMed ID: 30920415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease.
    Petta S; Valenti L; Marra F; Grimaudo S; Tripodo C; Bugianesi E; Cammà C; Cappon A; Di Marco V; Di Maira G; Dongiovanni P; Rametta R; Gulino A; Mozzi E; Orlando E; Maggioni M; Pipitone RM; Fargion S; Craxì A
    J Hepatol; 2016 Mar; 64(3):682-90. PubMed ID: 26596542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism.
    Musso G; Bo S; Cassader M; De Michieli F; Gambino R
    Am J Clin Nutr; 2013 Oct; 98(4):895-906. PubMed ID: 23985808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH.
    Musso G; Gambino R; Pacini G; Pagano G; Durazzo M; Cassader M
    Hepatology; 2009 Feb; 49(2):426-35. PubMed ID: 19105201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism.
    Musso G; Cassader M; Bo S; De Michieli F; Gambino R
    Diabetes; 2013 Apr; 62(4):1109-20. PubMed ID: 23274901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
    Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
    Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.
    Musso G; Cipolla U; Cassader M; Pinach S; Saba F; De Michieli F; Paschetta E; Bongiovanni D; Framarin L; Leone N; Berrutti M; Rosina F; Corvisieri S; Molinaro F; Sircana A; Gambino R
    J Lipid Res; 2017 Jun; 58(6):1221-1229. PubMed ID: 28242789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
    Musso G; Gambino R; Pacini G; De Michieli F; Cassader M
    Am J Clin Nutr; 2009 Feb; 89(2):558-67. PubMed ID: 19141695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.
    Musso G; Gambino R; De Michieli F; Durazzo M; Pagano G; Cassader M
    Hepatology; 2008 Apr; 47(4):1167-77. PubMed ID: 18311774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis.
    Musso G; Cassader M; De Michieli F; Saba F; Bo S; Gambino R
    Am J Clin Nutr; 2011 Oct; 94(4):1033-42. PubMed ID: 21865331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.
    Musso G; Gambino R; Cassader M
    J Nutr Biochem; 2010 Sep; 21(9):834-40. PubMed ID: 19733470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?
    Gambino R; Cassader M; Pagano G; Durazzo M; Musso G
    Hepatology; 2007 May; 45(5):1097-107. PubMed ID: 17464986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MERTK
    Junior ; Lai YS; Nguyen HT; Salmanida FP; Chang KT
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
    Musso G; Cassader M; De Michieli F; Paschetta E; Pinach S; Saba F; Bongiovanni D; Framarin L; Berrutti M; Leone N; Corvisieri S; Parente R; Molinaro F; Sircana A; Bo S; Gambino R
    Hum Mol Genet; 2017 May; 26(9):1785. PubMed ID: 28398481
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes.
    Zaharia OP; Strassburger K; Knebel B; Kupriyanova Y; Karusheva Y; Wolkersdorfer M; Bódis K; Markgraf DF; Burkart V; Hwang JH; Kotzka J; Al-Hasani H; Szendroedi J; Roden M;
    Diabetes Care; 2020 Sep; 43(9):2161-2168. PubMed ID: 32910776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory Markers.
    Kächele M; Hennige AM; Machann J; Hieronimus A; Lamprinou A; Machicao F; Schick F; Fritsche A; Stefan N; Nürnberg B; Häring HU; Staiger H
    PLoS One; 2015; 10(12):e0144494. PubMed ID: 26658747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.
    Zhou Y; Llauradó G; Orešič M; Hyötyläinen T; Orho-Melander M; Yki-Järvinen H
    J Hepatol; 2015 Mar; 62(3):657-63. PubMed ID: 25457209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.